Business Context and Reporting Period
This Form 6-K filing by MDXHealth SA covers the month of July 2024, with the report dated July 3, 2025. The filing primarily addresses significant changes to the Company's Board of Directors and executive management team.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Board Appointment: Michael Holder was appointed to the Board of Directors as Chair of the Audit Committee, effective July 3, 2025. He replaces Regine Slagmulder, whose term concluded in May 2025.
- CFO Resignation: Ron Kalfus resigned as Chief Financial Officer to pursue other opportunities.
- Interim Leadership: Scott McMahan, Vice President of Finance and Accounting, will assume CFO responsibilities on an interim basis starting July 30, 2025.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies were disclosed in this document other than the operational transition of the CFO role.
Investor Verification Checklist
- Verify the effective date of Michael Holder's appointment as Chair of the Audit Committee (July 3, 2025).
- Confirm the transition timeline for the CFO role, specifically the interim start date of July 30, 2025.
- Review the attached Press Release (Exhibit 99.1) for additional context on the leadership changes.
- Note that this filing does not include updated financial statements; refer to the most recent Form 20-F for financial data.